hims semaglutide fda & Hers launched a $49 weight loss pill last week, offering a compounded version of semaglutide, the active ingredient in approved drugs like Wegovy. Just 48 hours later, the company Hims Tumbles 19% After CEO

Potential treatment for polymorphic light eruption A 2010 phase III, randomized, double blind, placebo controlled, parallel group study was undertaken in Germany, the Netherlands, and Belgium to evaluate the safety and efficacy of subcutaneous implants of melanotan I (16 mg) in patients suffering from polymorphic light eruption (PLE), a condition characterized by a rash following exposure to sunlight

Hyperbaric oxygen directly increases oxygen availability to wounds while BPC-157 works through angiogenesis and cellular signaling

Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: in Vivo and in Vitro Studies in Rats

Because as revenue shrinks and ability to invest in new therapies goes down, the pharma companies, biopharmaceutical companies, are going to be hindered to invest in areas of unknown impact